FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220779743> ?p ?o ?g. }

• W4220779743 abstract "To ascertain the role of inflammation in the response to ocrelizumab in primary-progressive multiple sclerosis (PPMS).Multicenter prospective study including 69 patients with PPMS who initiated ocrelizumab treatment, classified according to baseline presence [Gd+, n=16] or absence [Gd-, n=53] of gadolinium-enhancing lesions in brain MRI. Ten Gd+ (62.5%) and 41 Gd- patients (77.4%) showed non-evidence of disease activity (NEDA) defined as no disability progression or new MRI lesions after 1 year of treatment. Blood immune cell subsets were characterized by flow cytometry, serum immunoglobulins by nephelometry, and serum neurofilament light-chains (sNfL) by SIMOA. Statistical analyses were corrected with the Bonferroni formula.More than 60% of patients reached NEDA after a year of treatment, regardless of their baseline characteristics. In Gd+ patients, it associated with a low repopulation rate of inflammatory B cells accompanied by a reduction of sNfL values 6 months after their first ocrelizumab dose. Patients in Gd- group also had low B cell numbers and sNfL values 6 months after initiating treatment, independent of their treatment response. In these patients, NEDA status was associated with a tolerogenic remodeling of the T and innate immune cell compartments, and with a clear increase of serum IgA levels.Baseline inflammation influences which immunological pathways predominate in patients with PPMS. Inflammatory B cells played a pivotal role in the Gd+ group and inflammatory T and innate immune cells in Gd- patients. B cell depletion can modulate both mechanisms." @default.
• W4220779743 created "2022-04-03" @default.
• W4220779743 creator A5000507468 @default.
• W4220779743 creator A5006085979 @default.
• W4220779743 creator A5010243880 @default.
• W4220779743 creator A5014149554 @default.
• W4220779743 creator A5014749222 @default.
• W4220779743 creator A5017037600 @default.
• W4220779743 creator A5017730233 @default.
• W4220779743 creator A5020255957 @default.
• W4220779743 creator A5021475528 @default.
• W4220779743 creator A5022338962 @default.
• W4220779743 creator A5025254958 @default.
• W4220779743 creator A5026079353 @default.
• W4220779743 creator A5026854823 @default.
• W4220779743 creator A5033677021 @default.
• W4220779743 creator A5039597568 @default.
• W4220779743 creator A5042076712 @default.
• W4220779743 creator A5042241522 @default.
• W4220779743 creator A5042355375 @default.
• W4220779743 creator A5047180263 @default.
• W4220779743 creator A5049239248 @default.
• W4220779743 creator A5063488081 @default.
• W4220779743 creator A5069442374 @default.
• W4220779743 creator A5072712902 @default.
• W4220779743 creator A5075497872 @default.
• W4220779743 creator A5075510658 @default.
• W4220779743 creator A5081187567 @default.
• W4220779743 creator A5083509914 @default.
• W4220779743 creator A5084095818 @default.
• W4220779743 creator A5085321363 @default.
• W4220779743 creator A5087278009 @default.
• W4220779743 creator A5088301395 @default.
• W4220779743 date "2022-03-21" @default.
• W4220779743 modified "2023-10-18" @default.
• W4220779743 title "Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology" @default.
• W4220779743 cites W1981621288 @default.
• W4220779743 cites W1990040006 @default.
• W4220779743 cites W2019482941 @default.
• W4220779743 cites W2086080135 @default.
• W4220779743 cites W2094682437 @default.
• W4220779743 cites W2105206040 @default.
• W4220779743 cites W2107008240 @default.
• W4220779743 cites W2123069839 @default.
• W4220779743 cites W2141075346 @default.
• W4220779743 cites W2142577589 @default.
• W4220779743 cites W2161607126 @default.
• W4220779743 cites W2489481562 @default.
• W4220779743 cites W2546632559 @default.
• W4220779743 cites W2565433170 @default.
• W4220779743 cites W2614808368 @default.
• W4220779743 cites W2767554904 @default.
• W4220779743 cites W2774037113 @default.
• W4220779743 cites W2777074421 @default.
• W4220779743 cites W2801419516 @default.
• W4220779743 cites W2892471745 @default.
• W4220779743 cites W2907217606 @default.
• W4220779743 cites W2910871825 @default.
• W4220779743 cites W2912154925 @default.
• W4220779743 cites W2967983128 @default.
• W4220779743 cites W2988261311 @default.
• W4220779743 cites W3101876475 @default.
• W4220779743 cites W3102446918 @default.
• W4220779743 cites W3120882765 @default.
• W4220779743 cites W3159017041 @default.
• W4220779743 cites W3183511191 @default.
• W4220779743 cites W4211048507 @default.
• W4220779743 cites W4253138417 @default.
• W4220779743 doi "https://doi.org/10.3389/fimmu.2022.842354" @default.
• W4220779743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35386690" @default.
• W4220779743 hasPublicationYear "2022" @default.
• W4220779743 type Work @default.
• W4220779743 citedByCount "1" @default.
• W4220779743 crossrefType "journal-article" @default.
• W4220779743 hasAuthorship W4220779743A5000507468 @default.
• W4220779743 hasAuthorship W4220779743A5006085979 @default.
• W4220779743 hasAuthorship W4220779743A5010243880 @default.
• W4220779743 hasAuthorship W4220779743A5014149554 @default.
• W4220779743 hasAuthorship W4220779743A5014749222 @default.
• W4220779743 hasAuthorship W4220779743A5017037600 @default.
• W4220779743 hasAuthorship W4220779743A5017730233 @default.
• W4220779743 hasAuthorship W4220779743A5020255957 @default.
• W4220779743 hasAuthorship W4220779743A5021475528 @default.
• W4220779743 hasAuthorship W4220779743A5022338962 @default.
• W4220779743 hasAuthorship W4220779743A5025254958 @default.
• W4220779743 hasAuthorship W4220779743A5026079353 @default.
• W4220779743 hasAuthorship W4220779743A5026854823 @default.
• W4220779743 hasAuthorship W4220779743A5033677021 @default.
• W4220779743 hasAuthorship W4220779743A5039597568 @default.
• W4220779743 hasAuthorship W4220779743A5042076712 @default.
• W4220779743 hasAuthorship W4220779743A5042241522 @default.
• W4220779743 hasAuthorship W4220779743A5042355375 @default.
• W4220779743 hasAuthorship W4220779743A5047180263 @default.
• W4220779743 hasAuthorship W4220779743A5049239248 @default.
• W4220779743 hasAuthorship W4220779743A5063488081 @default.
• W4220779743 hasAuthorship W4220779743A5069442374 @default.
• W4220779743 hasAuthorship W4220779743A5072712902 @default.
• W4220779743 hasAuthorship W4220779743A5075497872 @default.
• W4220779743 hasAuthorship W4220779743A5075510658 @default.
• W4220779743 hasAuthorship W4220779743A5081187567 @default.

• next